MIRA Pharmaceuticals Inc Sustainability Reports
MIRA Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics targeting neurologic, neuropsychiatric, inflammatory, and metabolic disorders.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 5493000N6HPDY7V7OR15
FIGI: BBG01H8XP681
1 reports from 2023 to 2023
